UnknownNot Applicable

Treatment Effect of Cross-frequency Transcranial Alternating Current Stimulation on the MUD

China32 participantsStarted 2023-10-15

Plain-language summary

The purpose of this research is to evaluate the efficacy of multiple sessions of theta-gamma cross-frequency transcranial alternating current stimulation in patients with methamphetamine (MA) use disorders.

Who can participate

Age range18 Years – 59 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders
✓. Normal vision and hearing
✓. Dextromanual
✓. Use MA not less than 1 year, and the last of MA use no less than 3 months

Exclusion criteria

✕. Have a disease that affects cognitive function such as a history of head injury, cerebrovascular disease, epilepsy, etc
✕. Have cognitive-promoting drugs in the last 6 months
✕. Other substance abuse or dependence in recent five years (except nicotine)
✕. Meet the DSM-5 criteria for other mental disorders
✕. Physical disease

What they're measuring

Change of Craving assessed by Visual Analog Scale

Timeframe: baseline，0-2 days after treatment，1 months after treatment, 3 months after treatment

Trial details

NCT IDNCT06145698

SponsorShanghai Mental Health Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-15

Contact for this trial

Min Zhao, PhD

021-54252689 18017311005@163.com

View on ClinicalTrials.gov More Amphetamine-Related Disorders trials